Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Opdam
High XIST and Low 53BP1 Expression Predict Poor Outcome After High-Dose Alkylating Chemotherapy in Patients With a BRCA1-like Breast Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
High-Dose Chemotherapy in High-Risk Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Low Expression of TFPI-2 Associated With Poor Survival Outcome in Patients With Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
High-Dose Chemotherapy (CTM) for Breast Cancer
Bone Marrow Transplantation
Transplantation
Hematology
The Feasibility of High-Dose Chemotherapy in Breast Cancer Patients With Impaired Left Ventricular Function
Bone Marrow Transplantation
Transplantation
Hematology
Fatigue and Relating Factors in High-Risk Breast Cancer Patients Treated With Adjuvant Standard or High-Dose Chemotherapy: A Longitudinal Study
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Is High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation in Breast Cancer Patients a Done Deal?
Women's Health
Medicine
High-Dose Chemotherapy and Haematopoietic Stem Cell Transplantation for Inflammatory Breast Cancer: Pathologic Response and Outcome
Bone Marrow Transplantation
Transplantation
Hematology
High Cyclin B1 Expression Is Associated With Poor Survival in Breast Cancer
British Journal of Cancer
Cancer Research
Oncology